Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals.

BACKGROUND Pediatric endocrinopathies are commonly diagnosed and monitored by measuring hormones of the hypothalamic-pituitary-gonadal axis. Because growth and development can markedly influence normal circulating concentrations of fertility hormones, accurate reference intervals established on the basis of a healthy, nonhospitalized pediatric population and that reflect age-, gender-, and pubertal stage-specific changes are essential for test result interpretation. METHODS Healthy children and adolescents (n = 1234) were recruited from a multiethnic population as part of the CALIPER study. After written informed parental consent was obtained, participants filled out a questionnaire including demographic and pubertal development information (assessed by self-reported Tanner stage) and provided a blood sample. We measured 7 fertility hormones including estradiol, testosterone (second generation), progesterone, sex hormone-binding globulin, prolactin, follicle-stimulating hormone, and luteinizing hormone by use of the Abbott Architect i2000 analyzer. We then used these data to calculate age-, gender-, and Tanner stage-specific reference intervals according to Clinical Laboratory Standards Institute C28-A3 guidelines. RESULTS We observed a complex pattern of change in each analyte concentration from the neonatal period to adolescence. Consequently, many age and sex partitions were required to cover the changes in most fertility hormones over this period. An exception to this was prolactin, for which no sex partition and only 3 age partitions were necessary. CONCLUSIONS This comprehensive database of pediatric reference intervals for fertility hormones will be of global benefit and should lead to improved diagnosis of pediatric endocrinopathies. The new database will need to be validated in local populations and for other immunoassay platforms as recommended by the Clinical Laboratory Standards Institute.

[1]  K. Adeli,et al.  A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals. , 2013, Clinical biochemistry.

[2]  D. Hellberg,et al.  Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study , 2012, Scandinavian journal of clinical and laboratory investigation.

[3]  K. Adeli,et al.  Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. , 2012, Clinical chemistry.

[4]  L. Dunkel,et al.  Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  W. Roberts,et al.  Selected performance characteristics of the Roche Elecsys testosterone II assay on the Modular analytics E 170 analyzer. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[6]  A. Rockwood,et al.  Limitations of the Hoffman approach to determine pediatric reference intervals for two steroids. , 2010, Clinical biochemistry.

[7]  A. Rockwood,et al.  Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. , 2010, Clinical chemistry.

[8]  O. Hiort,et al.  A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  L. Šaranac,et al.  Hyperprolactinemia: Different Clinical Expression in Childhood , 2010, Hormone Research in Paediatrics.

[10]  J. Bergquist,et al.  High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. , 2008, American journal of clinical pathology.

[11]  M. Hubert,et al.  Outlier detection for skewed data , 2008 .

[12]  F. Darendeliler,et al.  Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia. , 2006, The Turkish journal of pediatrics.

[13]  P. Twomey.  Reference Intervals: A User's Guide by PS Horn, AJ Pesce , 2006 .

[14]  O. Soldin,et al.  Pediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Elmlinger,et al.  Reference Ranges for Serum Concentrations of Lutropin (LH), Follitropin (FSH), Estradiol (E2), Prolactin, Progesterone, Sex Hormone-Binding Globulin (SHBG), Dehydroepiandrosterone Sulfate (DHEAS), Cortisol and Ferritin in Neonates, Children and Young Adults , 2002, Clinical chemistry and laboratory medicine.

[16]  Huaiqin Wu,et al.  Serum estradiol quantified by isotope dilution-gas chromatography/mass spectrometry. , 2002, Clinical chemistry.

[17]  N. Skakkebaek,et al.  A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  N. Rifai,et al.  Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. , 1995, Clinical biochemistry.

[19]  P. A. Lee,et al.  Normal ranges for immunochemiluminometric gonadotropin assays. , 1995, The Journal of pediatrics.

[20]  I. Huhtaniemi,et al.  Fetal Leydig Cells: Cellular Origin, Morphology, Life Span, and Special Functional Features , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  J C Boyd,et al.  On dividing reference data into subgroups to produce separate reference ranges. , 1990, Clinical chemistry.

[22]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[23]  D. Hull,et al.  Prolactin, maternal oestrogens, and breast development in the newborn. , 1981, Archives of disease in childhood.

[24]  N. M. Morris,et al.  Validation of a self-administered instrument to assess stage of adolescent development , 1980, Journal of youth and adolescence.

[25]  H. Friesen,et al.  Serum Prolactin Levels in Humans from Birth to Adult Life , 1973, Pediatric Research.

[26]  J M Tanner,et al.  Variations in the Pattern of Pubertal Changes in Boys , 1970, Archives of disease in childhood.

[27]  J M Tanner,et al.  Variations in pattern of pubertal changes in girls. , 1969, Archives of disease in childhood.

[28]  R. Kries,et al.  Accuracy of First and Second Generation Testosterone Assays and Improvement through Sample Extraction , 2012 .

[29]  D. Chevenne,et al.  Reference intervals for follicle-stimulating hormone, luteinizing hormone and prolactin in children and young adults on the bioMérieux Mini-Vidas system , 2007, Clinical chemistry and laboratory medicine.

[30]  M. Elmlinger,et al.  Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. , 2005, Clinical laboratory.

[31]  S. Bernasconi,et al.  Diagnosis of Central Precocious Puberty: Endocrine Assessment , 2000, Journal of pediatric endocrinology & metabolism : JPEM.